Condition
Degenerative Cervical Disc Disease
Total Trials
6
Recruiting
0
Active
1
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results75% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed3
Enrolling By Invitation1
Terminated1
Active Not Recruiting1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07001969Not ApplicableEnrolling By Invitation
Percutaneous Trans-facet Spine Fixation
NCT06876311Active Not RecruitingPrimary
Observational Study to Evaluate the STALIF® C FLX, STALIF® M FLX, STALIF® L FLX Cages and FORTOS-C®
NCT01491399Not ApplicableCompletedPrimary
INFUSE™ BONE GRAFT/CORNERSTONE-SR™ Allograft Ring/ATLANTIS™ Anterior Cervical Plate- Pilot Study
NCT00642876Not ApplicableCompletedPrimary
PRESTIGE® Cervical Disc Study
NCT00875810CompletedPrimary
PRESTIGE Observational Study
NCT01491477Not ApplicableTerminatedPrimary
INFUSE ® Bone Graft/CORNERSTONE-SR® Allograft Ring/ATLANTIS® Anterior Cervical Plate System Pivotal Trial
Showing all 6 trials